 longitudin studi symptomat infant human immunodefici viru infect evid bimod express clinic biolog symptom clinic biolog evolut infant vertic human immunodefici viru type infect consecut patient first clinic symptom express clinic symptom biolog abnorm bimod distribut patient earli sever diseas other progress third patient earli onset opportunist infect OI patient incid sever encephalopathi patient OI rate surviv year contrast patient earli OI sever encephalopathi probabl surviv year probabl occurr bacteri infect lymphoid interstiti pneumon lymphoid interstiti pneumon mean age month OI sever encephalopathi laboratori result initi examin clinic symptom number lymphocyt children life-threaten symptom OI sever encephalopathi vs true lymphocyt antigen stimul and/or antibodi absent serum antigen serum sever encephalopathi low anti-human immunodefici viru cerebrospin fluid antibodi titer patient moder encephalopathi sign intrathec anti-human immunodefici viru antibodi synthesi conclus subgroup patient earli sign sever immunodefici encephalopathi major patient surviv sever clinic symptom first year life